Evaluation of cutpoints for phenotypic hypersusceptibility to efavirenz

AIDS. 2003 Nov 7;17(16):2395-6. doi: 10.1097/00002030-200311070-00016.
No abstract available

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Alkynes
  • Anti-HIV Agents / pharmacology*
  • Benzoxazines
  • Cyclopropanes
  • Drug Resistance, Viral
  • HIV Reverse Transcriptase / antagonists & inhibitors
  • HIV-1 / drug effects*
  • Humans
  • Oxazines / pharmacology*
  • Proportional Hazards Models
  • Reverse Transcriptase Inhibitors / pharmacology

Substances

  • Alkynes
  • Anti-HIV Agents
  • Benzoxazines
  • Cyclopropanes
  • Oxazines
  • Reverse Transcriptase Inhibitors
  • HIV Reverse Transcriptase
  • efavirenz